DK3416984T3 - Kimært hunde-anti-cd20-antistof - Google Patents

Kimært hunde-anti-cd20-antistof Download PDF

Info

Publication number
DK3416984T3
DK3416984T3 DK17706644.6T DK17706644T DK3416984T3 DK 3416984 T3 DK3416984 T3 DK 3416984T3 DK 17706644 T DK17706644 T DK 17706644T DK 3416984 T3 DK3416984 T3 DK 3416984T3
Authority
DK
Denmark
Prior art keywords
chimered
antibody
dog anti
dog
chimered dog
Prior art date
Application number
DK17706644.6T
Other languages
English (en)
Inventor
James David Pancook
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Application granted granted Critical
Publication of DK3416984T3 publication Critical patent/DK3416984T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK17706644.6T 2016-02-18 2017-02-10 Kimært hunde-anti-cd20-antistof DK3416984T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662296729P 2016-02-18 2016-02-18
PCT/US2017/017337 WO2017142800A1 (en) 2016-02-18 2017-02-10 Chimeric canine anti-cd20 antibody

Publications (1)

Publication Number Publication Date
DK3416984T3 true DK3416984T3 (da) 2021-04-26

Family

ID=58098709

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17706644.6T DK3416984T3 (da) 2016-02-18 2017-02-10 Kimært hunde-anti-cd20-antistof

Country Status (14)

Country Link
US (4) US10519244B2 (da)
EP (1) EP3416984B1 (da)
JP (1) JP6661019B2 (da)
KR (1) KR102131544B1 (da)
CN (1) CN108699152B (da)
AU (1) AU2017219596B2 (da)
BR (1) BR112018016367A2 (da)
CA (1) CA3014461C (da)
DK (1) DK3416984T3 (da)
EA (1) EA039434B1 (da)
ES (1) ES2868650T3 (da)
MX (2) MX2018009955A (da)
NZ (1) NZ744192A (da)
WO (1) WO2017142800A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA039434B1 (ru) * 2016-02-18 2022-01-27 Эланко Юэс Инк. Химерное собачье анти-cd20 антитело
CN111182915A (zh) * 2017-08-15 2020-05-19 金德雷德生物科学股份有限公司 兽药用IgG Fc变体
JP2021059499A (ja) 2019-10-03 2021-04-15 日本全薬工業株式会社 イヌｃｄ２０に対するモノクローナル抗体又は抗体フラグメント
WO2022263864A1 (en) * 2021-06-17 2022-12-22 Petmedix Ltd Anti canine cd20 antibodies
WO2023010057A1 (en) * 2021-07-28 2023-02-02 Atreca, Inc. Atrc-101 target expression assay
GB202217993D0 (en) * 2022-11-30 2023-01-11 Petmedix Ltd Therapeutic antibodies

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151164B2 (en) * 2002-02-14 2006-12-19 Immunomedics, Inc. Anti-CD20 antibodies and fusion proteins thereof and methods of use
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
JP4745242B2 (ja) * 2003-05-20 2011-08-10 アプライド モレキュラー エボリューション，インコーポレイテッド Ｃｄ２０結合分子
WO2009086072A2 (en) * 2007-12-21 2009-07-09 Genentech, Inc. Therapy of rituximab-refractory rheumatoid arthritis patients
US8569460B2 (en) * 2009-03-25 2013-10-29 Vet Therapeutics, Inc. Antibody constant domain regions and uses thereof
EP2496604B1 (en) * 2009-11-06 2017-08-23 IDEXX Laboratories, Inc. Canine anti-cd20 antibodies
AU2011221553B2 (en) 2010-03-04 2016-05-26 Vet Therapeutics Inc. Monoclonal antibodies directed to CD20
GB201114858D0 (en) * 2011-08-29 2011-10-12 Nvip Pty Ltd Anti-nerve growth factor antibodies and methods of using the same
AU2012322445B2 (en) * 2011-10-13 2016-12-15 Nexvet Australia Pty Ltd Canine/feline CD20 binding epitope and compositions for binding thereto
EP2771694A4 (en) * 2011-10-26 2015-08-05 Novartis Tiergesundheit Ag MONOCLONAL ANTIBODIES AND METHOD FOR THEIR USE
WO2016016859A1 (en) * 2014-07-31 2016-02-04 Amgen Research (Munich) Gmbh Optimized cross-species specific bispecific single chain antibody constructs
EA039434B1 (ru) * 2016-02-18 2022-01-27 Эланко Юэс Инк. Химерное собачье анти-cd20 антитело

Also Published As

Publication number Publication date
ES2868650T3 (es) 2021-10-21
US20210163618A1 (en) 2021-06-03
KR102131544B1 (ko) 2020-07-07
EA039434B1 (ru) 2022-01-27
EP3416984B1 (en) 2021-03-31
BR112018016367A2 (pt) 2019-01-22
US20200131273A1 (en) 2020-04-30
CN108699152A (zh) 2018-10-23
US10941206B2 (en) 2021-03-09
EA201891499A1 (ru) 2019-01-31
US10519244B2 (en) 2019-12-31
JP6661019B2 (ja) 2020-03-11
CA3014461C (en) 2023-02-28
CA3014461A1 (en) 2017-08-24
CN108699152B (zh) 2022-08-19
US20230257476A1 (en) 2023-08-17
AU2017219596A1 (en) 2018-07-19
NZ744192A (en) 2019-11-29
JP2019507128A (ja) 2019-03-14
AU2017219596B2 (en) 2019-07-04
MX2022014375A (es) 2022-12-15
EP3416984A1 (en) 2018-12-26
MX2018009955A (es) 2018-11-29
KR20180096804A (ko) 2018-08-29
WO2017142800A1 (en) 2017-08-24
US20190194342A1 (en) 2019-06-27

Similar Documents

Publication Publication Date Title
DK3625259T3 (da) Anti-sirpalpha-antistoffer
DK3411404T3 (da) Psma- og cd3-bispecifikke t-celleinddragende antistofkonstruktioner
DK3344654T3 (da) Anti-lag-3-antistoffer
DK3405050T3 (da) Børnesikret snusbeholder
DK3350218T3 (da) Polyomavirus-neutraliserende antistoffer
DK3436823T3 (da) Antigen-array
DK3606961T3 (da) Garp-tgf-beta-antistoffer
DK3335532T3 (da) Tandharve
DK3250593T3 (da) Anti-transthyretin-antistoffer
DK3445708T3 (da) Stigbøjle
DK3416984T3 (da) Kimært hunde-anti-cd20-antistof
DK3402792T3 (da) Quinolin-2-on-derivater
DK3509963T3 (da) Pallecontainer
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
DK3154587T3 (da) Konjugater omfattende et anti-egfr1-antistof
DK3575238T3 (da) Pallecontainer
DE112017006386A5 (de) Schraubarbeitszylinder
DK3484921T3 (da) Anti-IL-22R antistoffer
DE112017000734A5 (de) Glycolsensor
DK3323708T3 (da) Bovfender
DK3456736T3 (da) Antistofvarianter
DK3452590T3 (da) Plademagnet
DK3471535T3 (da) Dyrelift
DK3452587T3 (da) Penicillin-g-acylaser
DK3430609T3 (da) Smartflag